Pagonabarraga, Javier

Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase

Pagonabarraga, J., Martinez‐Horta, S., Fernández de Bobadilla, R., Pérez, J., Ribosa‐Nogué, R., Marín, J., Pascual‐Sedano, B., García, C., Gironell, A., & Kulisevsky, J. (2016) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsHallucinations in medical conditions

Cited by 236

Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins

Martí-Fàbregas, J., Gomis, M., Arboix, A., Aleu, A., Pagonabarraga, J., Belvís, R., Cocho, D., Roquer, J., Rodríguez, A., García, M. D., et al. (2004) · Stroke

Acute Ischemic Stroke ManagementLipoproteins and Cardiovascular Health

Cited by 192

Understanding visual hallucinations: A new synthesis

Collerton, D., Barnes, J., Diederich, N. J., Dudley, R., ffytche, D., Friston, K., Goetz, C. G., Goldman, J. G., Jardri, R., Kulisevsky, J., et al. (2023) · Neuroscience & Biobehavioral Reviews

Hallucinations in medical conditionsVisual perception and processing mechanisms

Cited by 83

Parkinson disease psychosis: from phenomenology to neurobiological mechanisms

Pagonabarraga, J., Bejr-Kasem, H., Martinez-Horta, S., & Kulisevsky, J. (2024) · Nature Reviews Neurology

Parkinson's Disease Mechanisms and TreatmentsHallucinations in medical conditions

Cited by 69

Connectome-based brain fingerprints predict early cognitive decline in Parkinson’s patients with minor hallucinations

Stampacchia, S., Bernasconi, F., Van De Ville, D., Amico, E., Pagonabarraga, J., Kulisevsky, J., & Blanke, O. (2025) · bioRxiv (Cold Spring Harbor Laboratory)

Functional Brain Connectivity StudiesParkinson's Disease Mechanisms and Treatments

Cited by 5